| Thomas B Hazlehurst, M.d. | |
|
1900 Sullivan Ave Daly City CA 94015-2200 | |
| (650) 400-0277 | |
| (650) 340-1785 |
| Full Name | Thomas B Hazlehurst, M.d. |
|---|---|
| Speciality | Internal Medicine |
| Location | 1900 Sullivan Ave, Daly City, California |
| Authorized Official Name and Position | Thomas B Hazlehurst (CEO) |
| Authorized Official Contact | 6504000277 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Thomas B Hazlehurst, M.d. 39159 Paseo Padre Pkwy Suite 203 Fremont CA 94538-1608 Ph: (510) 505-1091 | Thomas B Hazlehurst, M.d. 1900 Sullivan Ave Daly City CA 94015-2200 Ph: (650) 400-0277 |
| NPI Number | 1205846789 |
|---|---|
| Provider Enumeration Date | 08/08/2006 |
| Last Update Date | 03/12/2014 |
| Medicare PECOS PAC ID | 7315980414 |
|---|---|
| Medicare Enrollment ID | O20050609000558 |
News Archive
A review and analysis of 26 validated hospital readmission risk prediction models finds that most, whether for hospital comparison or clinical purposes, have poor predictive ability, according to an article in the October 19 issue of JAMA.
Smoking while having diabetes is a deadly combination - in recognition of the World Health Organization's World No Tobacco Day taking place on May 31, 2010, the Canadian Diabetes Association is urging Canadians living with diabetes who smoke to take charge of their health by knowing their risks and to take action to quit smoking.
Diagnostic Devices, Inc. (DDI), the maker of Prodigy(R) blood glucose monitoring systems, and the leading provider of audible meters, is leading what could be a made-in-America revolution by doing the unthinkable and bringing manufacturing jobs home from China, according to experts in international trade.
Novartis today presented results from a pivotal Phase III trial of investigational therapy Signifor® LAR (pasireotide LAR; SOM230) in patients with acromegaly for whom current standard of care provides inadequate disease control.
In a groundbreaking policy paper released today, the American College of Physicians (ACP) offered more than a dozen principles for engaging the public in a process that it hopes will lead to consensus on conserving and allocating resources based on the best evidence of clinical effectiveness and value.
› Verified 4 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205846789 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | G37365 (California) | Primary |
| Provider Name | Donna Maria Puzon |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1801949524 PECOS PAC ID: 2567555717 Enrollment ID: I20070905000308 |
News Archive
A review and analysis of 26 validated hospital readmission risk prediction models finds that most, whether for hospital comparison or clinical purposes, have poor predictive ability, according to an article in the October 19 issue of JAMA.
Smoking while having diabetes is a deadly combination - in recognition of the World Health Organization's World No Tobacco Day taking place on May 31, 2010, the Canadian Diabetes Association is urging Canadians living with diabetes who smoke to take charge of their health by knowing their risks and to take action to quit smoking.
Diagnostic Devices, Inc. (DDI), the maker of Prodigy(R) blood glucose monitoring systems, and the leading provider of audible meters, is leading what could be a made-in-America revolution by doing the unthinkable and bringing manufacturing jobs home from China, according to experts in international trade.
Novartis today presented results from a pivotal Phase III trial of investigational therapy Signifor® LAR (pasireotide LAR; SOM230) in patients with acromegaly for whom current standard of care provides inadequate disease control.
In a groundbreaking policy paper released today, the American College of Physicians (ACP) offered more than a dozen principles for engaging the public in a process that it hopes will lead to consensus on conserving and allocating resources based on the best evidence of clinical effectiveness and value.
› Verified 4 days ago
| Provider Name | Thomas B Hazlehurst |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1205846771 PECOS PAC ID: 4486697588 Enrollment ID: I20100723000629 |
News Archive
A review and analysis of 26 validated hospital readmission risk prediction models finds that most, whether for hospital comparison or clinical purposes, have poor predictive ability, according to an article in the October 19 issue of JAMA.
Smoking while having diabetes is a deadly combination - in recognition of the World Health Organization's World No Tobacco Day taking place on May 31, 2010, the Canadian Diabetes Association is urging Canadians living with diabetes who smoke to take charge of their health by knowing their risks and to take action to quit smoking.
Diagnostic Devices, Inc. (DDI), the maker of Prodigy(R) blood glucose monitoring systems, and the leading provider of audible meters, is leading what could be a made-in-America revolution by doing the unthinkable and bringing manufacturing jobs home from China, according to experts in international trade.
Novartis today presented results from a pivotal Phase III trial of investigational therapy Signifor® LAR (pasireotide LAR; SOM230) in patients with acromegaly for whom current standard of care provides inadequate disease control.
In a groundbreaking policy paper released today, the American College of Physicians (ACP) offered more than a dozen principles for engaging the public in a process that it hopes will lead to consensus on conserving and allocating resources based on the best evidence of clinical effectiveness and value.
› Verified 4 days ago
| Provider Name | Celso Q Huiso |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1144624958 PECOS PAC ID: 4587967021 Enrollment ID: I20160118000009 |
News Archive
A review and analysis of 26 validated hospital readmission risk prediction models finds that most, whether for hospital comparison or clinical purposes, have poor predictive ability, according to an article in the October 19 issue of JAMA.
Smoking while having diabetes is a deadly combination - in recognition of the World Health Organization's World No Tobacco Day taking place on May 31, 2010, the Canadian Diabetes Association is urging Canadians living with diabetes who smoke to take charge of their health by knowing their risks and to take action to quit smoking.
Diagnostic Devices, Inc. (DDI), the maker of Prodigy(R) blood glucose monitoring systems, and the leading provider of audible meters, is leading what could be a made-in-America revolution by doing the unthinkable and bringing manufacturing jobs home from China, according to experts in international trade.
Novartis today presented results from a pivotal Phase III trial of investigational therapy Signifor® LAR (pasireotide LAR; SOM230) in patients with acromegaly for whom current standard of care provides inadequate disease control.
In a groundbreaking policy paper released today, the American College of Physicians (ACP) offered more than a dozen principles for engaging the public in a process that it hopes will lead to consensus on conserving and allocating resources based on the best evidence of clinical effectiveness and value.
› Verified 4 days ago
| Provider Name | Soraya Mangondato-galvan |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1881755072 PECOS PAC ID: 7517219629 Enrollment ID: I20181017001866 |
News Archive
A review and analysis of 26 validated hospital readmission risk prediction models finds that most, whether for hospital comparison or clinical purposes, have poor predictive ability, according to an article in the October 19 issue of JAMA.
Smoking while having diabetes is a deadly combination - in recognition of the World Health Organization's World No Tobacco Day taking place on May 31, 2010, the Canadian Diabetes Association is urging Canadians living with diabetes who smoke to take charge of their health by knowing their risks and to take action to quit smoking.
Diagnostic Devices, Inc. (DDI), the maker of Prodigy(R) blood glucose monitoring systems, and the leading provider of audible meters, is leading what could be a made-in-America revolution by doing the unthinkable and bringing manufacturing jobs home from China, according to experts in international trade.
Novartis today presented results from a pivotal Phase III trial of investigational therapy Signifor® LAR (pasireotide LAR; SOM230) in patients with acromegaly for whom current standard of care provides inadequate disease control.
In a groundbreaking policy paper released today, the American College of Physicians (ACP) offered more than a dozen principles for engaging the public in a process that it hopes will lead to consensus on conserving and allocating resources based on the best evidence of clinical effectiveness and value.
› Verified 4 days ago
News Archive
A review and analysis of 26 validated hospital readmission risk prediction models finds that most, whether for hospital comparison or clinical purposes, have poor predictive ability, according to an article in the October 19 issue of JAMA.
Smoking while having diabetes is a deadly combination - in recognition of the World Health Organization's World No Tobacco Day taking place on May 31, 2010, the Canadian Diabetes Association is urging Canadians living with diabetes who smoke to take charge of their health by knowing their risks and to take action to quit smoking.
Diagnostic Devices, Inc. (DDI), the maker of Prodigy(R) blood glucose monitoring systems, and the leading provider of audible meters, is leading what could be a made-in-America revolution by doing the unthinkable and bringing manufacturing jobs home from China, according to experts in international trade.
Novartis today presented results from a pivotal Phase III trial of investigational therapy Signifor® LAR (pasireotide LAR; SOM230) in patients with acromegaly for whom current standard of care provides inadequate disease control.
In a groundbreaking policy paper released today, the American College of Physicians (ACP) offered more than a dozen principles for engaging the public in a process that it hopes will lead to consensus on conserving and allocating resources based on the best evidence of clinical effectiveness and value.
› Verified 4 days ago
Pediahealth Medical Group, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 901 Campus Dr, Suite 210, Daly City, CA 94015 Phone: 650-994-3000 | |
John W. Wilson, Md, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1800 Sullivan Ave, Room 503, Daly City, CA 94015 Phone: 650-994-9090 Fax: 650-994-9093 | |
Daly City Youth Hlth Ctr Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 350 90th Street, Daly City, CA 94015 Phone: 650-985-7000 Fax: 605-301-8626 | |
Divya R Kini Md Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1500 Southgate Avenue, Divya Kini Md Inc Suite 204, Daly City, CA 94015 Phone: 650-755-2192 Fax: 650-745-0710 | |
North East Medical Services - Eastmoor Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 211 Eastmoor Ave, Daly City, CA 94015 Phone: 415-391-9686 | |
Ellick Tsang M D Corporation Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1800 Sullivan Ave, Suite 304, Daly City, CA 94015 Phone: 650-992-8484 Fax: 650-992-8480 | |
Medisina Sa Familia, Pa, Md Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1850 Sullivan Ave Ste 510, Daly City, CA 94015 Phone: 650-580-6479 Fax: 650-735-5580 |